The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Sepsis Diagnostics Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The sepsis diagnostics market size has experienced significant growth in recent years. It is anticipated to expand from $1.07 billion in 2025 to $1.16 billion in 2026, at a compound annual growth rate (CAGR) of 8.3%. This historical growth can be linked to factors such as an increase in hospital-acquired infections, the embrace of rapid diagnostic tests, various regulatory approvals, improvements in advanced lab infrastructure, and a growing clinical awareness.
The sepsis diagnostics market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $1.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the forecast period include the advent of AI-enabled diagnostic platforms, increased biomarker-based testing, the integration of tele-diagnostics, innovative sepsis detection assays, and the proliferation of point-of-care diagnostics. Key developments expected in this period encompass point-of-care diagnostic devices, tests utilizing biomarkers, rapid blood culture kits, AI-assisted diagnostic platforms, and their integration with hospital IT infrastructure.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23514&type=smp
What Drivers Are Influencing The Sepsis Diagnostics Market?
The increasing occurrence of infections acquired in hospitals is projected to fuel the expansion of the sepsis diagnostics market moving forward. Hospital-acquired infections (HAIs) are defined as infections that emerge either during a patient’s stay in a healthcare setting or subsequently, typically 48 hours or more following admission, and were not present upon initial admission. This escalation in hospital-acquired infections stems from a rise in antibiotic resistance. Excessive and inappropriate use of antibiotics within healthcare environments has fostered the development of drug-resistant bacteria, making infections harder to treat. Sepsis diagnostic tools facilitate the early detection of hospital-acquired infections through the identification of pathogens and specific biomarkers, thereby enabling prompt treatment and mitigating potential complications. As an illustration, in November 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that during 2022–23, HACs were observed in 2% of public hospital admissions and 0.8% of private hospital admissions, with healthcare-associated infections representing the most frequent complication. Consequently, the growing prevalence of infections acquired in hospitals is a significant factor driving growth within the sepsis diagnostics market.
What Major Segment Divisions Exist Within The Sepsis Diagnostics Market?
The sepsis diagnostics market covered in this report is segmented –
1) By Product: Instruments, Blood Culture Media, Assay Kits And Reagents, Software
2) By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Other Technologies
3) By Pathogen: Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Other Pathogens
4) By Method: Automated Diagnostics, Conventional Diagnostics
5) By End-Users: Hospitals And Clinics, Pathology And Reference Laboratories, Research Institutes
Subsegments:
1) By Instruments: Automated Analyzers, Point-Of-Care (PoC) Testing Devices, Microfluidic-Based Devices, Polymerase Chain Reaction (PCR) Instruments, Flow Cytometers
2) By Blood Culture Media: Aerobic Blood Culture Media, Anaerobic Blood Culture Media, Mycobacteria Blood Culture Media, Pediatric Blood Culture Media, Fungal Blood Culture Media
3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Polymerase Chain Reaction (PCR) Assay Kits, Immunoassay Reagents, Molecular Diagnostic Reagents, Biosensor-Based Assay Kits
4) By Software: Data Management Software, Laboratory Information Systems (LIS), Artificial Intelligence (AI)-Based Diagnostic Tools, Predictive Analytics Software, Cloud-Based Diagnostic Platforms
What Trends Are Projected To Affect The Sepsis Diagnostics Market?
Leading companies in the sepsis diagnostics market are concentrating on the development of innovative solutions, such as culture-free diagnostic solutions, aimed at enabling quick and precise detection of sepsis without relying on conventional blood cultures. A culture-free diagnostic solution represents a method for identifying pathogens or infections that bypasses the need for traditional microbial culture techniques. These solutions leverage advanced technologies, including polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays, to rapidly identify pathogens directly from patient samples like blood, saliva, or tissue. For instance, in April 2024, Deepull Diagnostics S.L., a Spain-based manufacturing company, launched the UllCORE diagnostic system, designed for early sepsis detection. The UllCORE system is a benchtop, culture-free multiplex PCR platform, developed by Deepull, specifically for the rapid identification of pathogens in sepsis and other acute infections. It extracts microbial DNA from 8 mL of whole blood and delivers 50 reportable results within one hour. This system detects 95% of sepsis-causing pathogens, including bacteria, fungi, and antibiotic resistance genes. Designed to improve early diagnosis and diminish antibiotic misuse, UllCORE supports hospitals in their efforts to combat antimicrobial resistance.
Which Companies Are Leading Innovation In The Sepsis Diagnostics Market?
Major companies operating in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMérieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., EKF Diagnostics Holdings plc, Boditech Med Inc., Alifax S.r.l., Abionic SA
Read the full sepsis diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/sepsis-diagnostics-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Sepsis Diagnostics Market?
North America was the largest region in the sepsis diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sepsis Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23514&type=smp
Browse Through More Reports Similar to the Global Sepsis Diagnostics Market 2026, By The Business Research Company
Hospital Acquired Infection Control Global Market Report
Hemophilia Global Market Report
https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report
Clinical Microbiology Global Market Report
https://www.thebusinessresearchcompany.com/report/clinical-microbiology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model